Skip to main content
. 2023 Feb 25;77(7):3791–3802. doi: 10.1007/s11696-023-02741-3

Table 2.

Antitubercular activity in MIC in μM (μg/mL) of compounds 8a–p

Compound R R1 M. tuberculosis, H37 RV
8a H Methyl 14.4 (3.12)
8b H Ethyl 27.1 (6.25)
8c H n-Propyl 102 (25)
8d H n-Butyl 24.1 (6.25)
8e Br Methyl 21.2 (6.25)
8f Br Ethyl 20.2 (6.25)
8g Br n-Propyl 19.3 (6.25)
8h Br n-Butyl 9.2 (3.12)
8i Cl Methyl 24.9 (6.25)
8j Cl Ethyl 47.2 (12.5)
8k Cl n-Propyl 22.4 (6.25)
8l Cl n-Butyl 42.7 (12.5)
8m F Methyl 106.4 (25)
8n F Ethyl 401.6 (100)
8o F n-Propyl 190.1 (50)
8p F n-Butyl 180.5 (50)
Pyrazinamide 25.34 (3.12)
Isoniazid 11.67 (1.6)